Navigation Links
Austen BioInnovation Institute in Akron Begins Work on Roadmap for First U.S. Accountable Care Community

AKRON, Ohio, June 22, 2011 /PRNewswire-USNewswire/ -- With the intent to create a healthier community and lessen the burden of disease in Akron, the Austen BioInnovation Institute in Akron (ABIA) has launched its Accountable Care Community initiative at the conference "Healthier by Design: Creating Accountable Care Communities" held today.

Led by national and regional health and wellness thought-leaders, the strategic discussion is the first step in building a plan of health promotion and disease prevention that determines how to best deliver and provide access to quality care and services for the entire community. The ABIA initiative, known as Accountable Care Community (ACC), integrates area assets into a shared responsibility framework among regional institutions to enable improvement in population health, to close gaps in healthcare delivery, and to measure impact as innovative health strategies are implemented, according to Dr. Janine E. Janosky, Vice President of ABIA's Center for Clinical and Community Health Improvement.

"The purpose of creating an ACC is to develop a sustainable health model for the Akron region that will lessen the burden of disease, and achieve a level of success that can be replicated across the country," states Dr. Frank L. Douglas, ABIA President and CEO. "In implementing an Accountable Care Community, we will reduce health care costs and improve lives and the productivity of our community."

The ACC effort is at the forefront of developing healthier communities and has great significance in light of recent healthcare reforms at the national level and increasing prominence of Accountable Care Organizations (ACO).  An ACO is a network of doctors and hospitals that share responsibility for providing care to patients.

Taking this concept one step further, an ACC uses a collaborative, multi-institution approach that emphasizes a shared responsibility for the health of the community. By focusing on chronic diseases, such as diabetes, obesity, asthma and hypertension, and integrating the efforts of health-focused community organizations, community wellness and quality of life increases. Additionally, ACCs lower healthcare costs and increase productivity thus benefitting the local economy.

The development of an ACC speaks to the principles that ABIA was founded upon, which includes the aspiration to be nationally distinct in improving health outcomes with a focus upon the medically underserved.

"The goal of the ACC is to create a sustainable health model in Akron that can then be adapted and delivered in other communities," says Janosky.

The initiative's steering committee continues to develop a white paper to further guide Akron's development of an ACC that will further expand the efficiency of budgets and resources, and develop research to improve health through community and practice-based interventions.

About the Austen BioInnovation Institute in Akron

The Austen BioInnovation Institute in Akron (ABIA) – an exceptional collaboration of Akron Children's Hospital, Akron General Health System, Northeast Ohio Medical University (formerly Northeastern Ohio Universities Colleges of Medicine and Pharmacy), Summa Health System, The University of Akron and The John S. and James L. Knight Foundation – is focused on patient-centered innovation and commercialization at the intersection of biomaterials and medicine. The strategic alignment of public and private support, accompanied with Akron's rich legacy in materials science, is working to pioneer the next generation of life-enhancing and life-saving innovation that will transform Akron into a model for biomedical discovery and enterprise and move the region toward a secure economic future by accelerating the creation of over 2,000 jobs during the next decade. For more information about ABIA, please visit

Media Contact:
Scott Rainone
Austen BioInnovation Institute in Akron

SOURCE Austen BioInnovation Institute in Akron
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioInnovation Institute in Akron Launched
2. Colorado Institute for Drug, Device and Diagnostic Development Awards Funding to Fort Collins-based VetDC
3. Karlsruhe Institute of Technology: Self-assembling electronic nano-components
4. Max Institute of Minimal Access, Metabolic & Bariatric Surgery Accredited as an International Centre of Excellence for Minimal Invasive Surgery
5. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
6. Arteriocyte and the U.S. Army Institute of Surgical Research (USAISR) Sign a CRADA to Speed Development of Cellular Therapies for Orthopaedic Trauma
7. Ontario Institute for Cancer Research Announces Spin Off Companies Developing Promising Anticancer Technologies
8. Ludwig Institute for Cancer Research and Polaris Group Form Collaboration to Expand Development of Polaris Novel Cancer Drug, ADI-PEG 20
9. Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
10. Larta Institute Receives Award for National Institutes of Health Commercialization Assistance Program at 2011 Acquisition, Grants, and Small Business Symposium
11. Van Andel Institute Earns Highest "Green Building" Award
Post Your Comments:
(Date:11/24/2015)... -- Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting ... Israel time, at the law offices of ... th Floor, Tel Aviv, Israel . ... Izhak Tamir to the Board of Directors; , election of ... approval of an amendment to certain terms of options granted to our ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Technologies, Inc., on being named to Deloitte's 2015 Technology Fast 500 list of ... OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up orthodontic ...
(Date:11/24/2015)... NEW YORK , November 24, 2015 ... Squibb in a European healthcare ... in which the companies will work closely together in ... areas of unmet medical need. The collaboration is underpinned by ... latest LSP fund. This is the first investment by Bristol-Myers ...
(Date:11/23/2015)... -- China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing, and ... financial results for the second quarter and first half ... --> --> Second Quarter ... second quarter of fiscal 2016 increased by 12.7% to ...
Breaking Biology Technology:
(Date:11/19/2015)... NEW YORK , Nov. 19, 2015  Although ... the market is dominated by a few companies, according ... Qiagen. These companies own 51% of the market share of ... report, The World Market for Molecular Diagnostic ... "The market is still controlled by one ...
(Date:11/17/2015)... PARIS , November 17, 2015 ... 17 au 19 novembre  2015.  --> Paris ... 2015.  --> DERMALOG, le leader de l,innovation ... à la fois passeports et empreintes sur la même ... pour les passeports et l,autre pour les empreintes digitales. ...
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
Breaking Biology News(10 mins):